MVSSX
Price
$32.84
Change
+$0.51 (+1.58%)
Updated
Sep 4 closing price
Net Assets
1.07B
VISVX
Price
$50.57
Change
+$0.21 (+0.42%)
Updated
Sep 5 closing price
Net Assets
59.22B
Interact to see
Advertisement

MVSSX vs VISVX

Header iconMVSSX vs VISVX Comparison
Open Charts MVSSX vs VISVXBanner chart's image
Victory Integrity Small-Cap Value R6
Price$32.84
Change+$0.51 (+1.58%)
VolumeN/A
Net Assets1.07B
Vanguard Small Cap Value Index I
Price$50.57
Change+$0.21 (+0.42%)
VolumeN/A
Net Assets59.22B
MVSSX vs VISVX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
MVSSX vs. VISVX commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MVSSX is a Buy and VISVX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VISVX has more cash in the bank: 59.2B vs. MVSSX (1.07B). VISVX pays higher dividends than MVSSX: VISVX (1.86) vs MVSSX (1.64). MVSSX was incepted earlier than VISVX: MVSSX (13 years) vs VISVX (27 years). MVSSX (0.96) is less costly to investors than VISVX (0.19). MVSSX is a more actively managed with annual turnover of: 62.00 vs. VISVX (16.00). MVSSX has a lower initial minimum investment than VISVX: MVSSX (0) vs VISVX (3000). VISVX annual gain was more profitable for investors over the last year : 10.19 vs. MVSSX (-7.66). VISVX return over 5 years is better than : 86.20 vs. MVSSX (24.15).
MVSSXVISVXMVSSX / VISVX
Total Expense Ratio0.960.19505%
Annual Report Gross Expense Ratio0.960.19505%
Fund Existence13 years27 years-
Gain YTD4.0566.66561%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.07B59.2B2%
Annual Yield % from dividends1.641.8688%
Returns for 1 year-7.6610.19-75%
Returns for 3 years-3.9336.58-11%
Returns for 5 years24.1586.2028%
Returns for 10 years8.30117.427%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LOAR76.482.75
+3.73%
Loar Holdings
GLUE4.940.03
+0.61%
Monte Rosa Therapeutics
JANX23.980.04
+0.17%
Janux Therapeutics
JPM294.38-9.44
-3.11%
JPMorgan Chase & Co
RENB0.21-0.01
-3.23%
Renovaro